Trial Outcomes & Findings for ProGripTM Self-Gripping Polyester Mesh in Incisional Hernia Prevention (NCT NCT03912662)

NCT ID: NCT03912662

Last Updated: 2025-12-03

Results Overview

Incisional hernia rate within 24 months of midline laparotomy assessed by CT-scan and physical examination including hernia clinical examination.

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

32 participants

Primary outcome timeframe

24 months

Results posted on

2025-12-03

Participant Flow

A subject is considered enrolled in the study when it is confirmed they meet all pre-operative inclusion and no exclusion criteria, the Informed Consent Form is signed and they have been implanted with the device.

Participant milestones

Participant milestones
Measure
Patients Consented for POETRY Study
Patients consented for POETRY Study and may recieve ProGrip™ Self-Gripping Polyester Mesh.
Overall Study
STARTED
35
Overall Study
Enrolled (Received Study Device)
32
Overall Study
Safety Analysis Set
32
Overall Study
COMPLETED
6
Overall Study
NOT COMPLETED
29

Reasons for withdrawal

Reasons for withdrawal
Measure
Patients Consented for POETRY Study
Patients consented for POETRY Study and may recieve ProGrip™ Self-Gripping Polyester Mesh.
Overall Study
Adverse Event
3
Overall Study
Adverse Event and Death
1
Overall Study
Death
1
Overall Study
Screen Failure: Subjects who provide study consent, but then were determined to be ineligible.
1
Overall Study
Mesh Removal
1
Overall Study
Discontinued: Eligible consented subjects who did not undergo the procedure with the study device.
2
Overall Study
Early study termination
20

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Patients Treated With ProGrip™ Self-Gripping Polyester Mesh
n=32 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled who received the ProGrip™ Self-Gripping Polyester Mesh
Age, Continuous
69.1 years
STANDARD_DEVIATION 13.19 • n=32 Participants
Sex: Female, Male
Female
13 Participants
n=32 Participants
Sex: Female, Male
Male
19 Participants
n=32 Participants
Weight
73.6 kg
STANDARD_DEVIATION 17.96 • n=32 Participants
Height
169.5 cm
STANDARD_DEVIATION 9.26 • n=32 Participants
BMI
25.5 kg/m^2
STANDARD_DEVIATION 5.66 • n=32 Participants
Work
Unemployed
16 Participants
n=32 Participants
Work
Administrative work
4 Participants
n=32 Participants
Work
Moderately physical labor
5 Participants
n=32 Participants
Work
Physical labor
3 Participants
n=32 Participants
Work
Not Provided
4 Participants
n=32 Participants
Sport Activity
None
14 Participants
n=32 Participants
Sport Activity
Intense (>1x/week)
3 Participants
n=32 Participants
Sport Activity
Moderate (1x/week)
14 Participants
n=32 Participants
Sport Activity
Sporadic
1 Participants
n=32 Participants

PRIMARY outcome

Timeframe: 24 months

Population: Patients who received ProGrip Self-Gripping Polyester Mesh for suture line reinforcement after midline laparotomy, met all of the inclusion criteria, and none of the exclusion criteria.

Incisional hernia rate within 24 months of midline laparotomy assessed by CT-scan and physical examination including hernia clinical examination.

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=4 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Incisional Hernia Rate
1 Participants

SECONDARY outcome

Timeframe: From the surgery to the 24-month visit

Population: Patients who received ProGrip Self-Gripping Polyester Mesh for suture line reinforcement after midline laparotomy, met all of the inclusion criteria, and none of the exclusion criteria.

AE incidence reported by number, seriousness, and relationship to the procedure and device from the surgery to the 24-month visit

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=32 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Adverse Event
Total Number of Adverse Events
39 Adverse Events
Adverse Event
AEs by reason for Seriousness: Hospitalization
18 Adverse Events
Adverse Event
AEs by reason for Seriousness: Death
2 Adverse Events
Adverse Event
AEs by reason for Seriousness: Life threatening illness or injury
8 Adverse Events
Adverse Event
AEs by reason for Seriousness: Permanent impairment of a body structure or body function
1 Adverse Events
Adverse Event
AEs by reason for Seriousness: Medical or surgical intervention
19 Adverse Events
Adverse Event
AEs by Relation to Study Device: Not Related
31 Adverse Events
Adverse Event
AEs by Relation to Index Procedure: Not Related
12 Adverse Events
Adverse Event
AEs by Relation to Index Procedure: Related
27 Adverse Events
Adverse Event
AEs by Relation to Mesh Placement Procedure: Not Related
24 Adverse Events
Adverse Event
AEs by Relation to Mesh Placement Procedure: Related
4 Adverse Events
Adverse Event
Number of Index Procedure related AEs
27 Adverse Events
Adverse Event
Number of Index Procedure related SAEs
14 Adverse Events
Adverse Event
Number of AEs with action taken
38 Adverse Events
Adverse Event
AEs by Relation to Study Device: Related
8 Adverse Events
Adverse Event
Number of SAEs
25 Adverse Events
Adverse Event
Number of non-Serious AEs
14 Adverse Events
Adverse Event
Number of Device-Related AEs
8 Adverse Events
Adverse Event
Number of Mesh Placement Procedure-related AEs
5 Adverse Events
Adverse Event
Number of Device-related SAEs
6 Adverse Events
Adverse Event
Number of Mesh Placement Procedure-related SAEs
3 Adverse Events

SECONDARY outcome

Timeframe: From the surgery to the 24-month visit

Population: Patients who received ProGrip Self-Gripping Polyester Mesh for suture line reinforcement after midline laparotomy, met all of the inclusion criteria, and none of the exclusion criteria.

Time to incisional hernia occurrence from the surgery to the 24-month visit

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=32 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Time to Incisional Hernia Occurrence
384 Days to hernia occurrence
Interval 384.0 to 384.0

SECONDARY outcome

Timeframe: Day 0, Day 1, Day 8, Month 1, Month 12, Month 24

Population: Patients who received ProGrip Self-Gripping Polyester Mesh for suture line reinforcement after midline laparotomy, met all of the inclusion criteria, and none of the exclusion criteria.

Post-operative pain at the site of the surgery was measured at days 0, 1, 8 and months 1, 12, 24 using a Visual Analog Scale - a psychometric response scale (0-10) (0 no pain, 10 the worst) either during systematic clinical visit or by phone call when a subject is already discharged. (Worst pain experienced over the last 24 hours).

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=30 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Post-operative Pain at the Site of Surgery
EVA (VAS) Day 0
3.8 score on a scale of 0-10
Standard Deviation 2.94
Post-operative Pain at the Site of Surgery
EVA (VAS) Day 1
3.7 score on a scale of 0-10
Standard Deviation 2.73
Post-operative Pain at the Site of Surgery
EVA (VAS) Month 24
0 score on a scale of 0-10
Standard Deviation 0
Post-operative Pain at the Site of Surgery
EVA (VAS) Day 8
1.9 score on a scale of 0-10
Standard Deviation 2.42
Post-operative Pain at the Site of Surgery
EVA (VAS) Month 1
0.4 score on a scale of 0-10
Standard Deviation 0.91
Post-operative Pain at the Site of Surgery
EVA (VAS) Month 12
0.5 score on a scale of 0-10
Standard Deviation 1.81

SECONDARY outcome

Timeframe: Month 1, Month 12, Month 24

Population: Patients who received ProGrip Self-Gripping Polyester Mesh for suture line reinforcement after midline laparotomy, met all of the inclusion criteria, and none of the exclusion criteria.

Assessment with Club Hernie Registry QOL questionnaire of patients treated with ProGrip Self-Gripping Polyester Mesh for suture line mesh reinforcement. . Two sets of self-administered QOL were administered; one for 1 month and one for 12- and 24-month.

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=25 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Quality of Life Questionnaire (QOL) for Patient
Month 1 : Post-operative discomfort: No symptoms
16 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1 : Post-operative discomfort: Discomfort
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Post-operative discomfort: Other symptoms
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24 : Post-operative discomfort: No symptoms
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Post-operative discomfort: Reduced sensitivity
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Location of symptoms: Not applicable
17 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Location of symptoms: Side operated on
6 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Location of symptoms: Contralateral
2 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Location of symptoms: Elsewhere
2 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Location of symptoms: Response missing
7 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Timing of symptoms: Not applicable
19 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Timing of symptoms: after exertion or end of day
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Timing of symptoms: Anytime
2 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Timing of symptoms: During other activities
2 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Timing of symptoms: Response missing
7 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Frequency of symptoms: Not applicable
19 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Frequency of symptoms: Several times per day
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Frequency of symptoms: Often during day
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Impact of symptoms on activities: Not applicable
19 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Impact of symptoms on activities: prohibits certain activities
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Impact of symptoms on activities: temporary stop of activities
2 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Impact of symptoms on activities: continue activities
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Impact of symptoms on activities: response missing
7 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: pre- and post-operative pain: Not applicable
21 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: pre- and post-operative pain: post-operative discomfort < Hernia discomfort
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: pre- and post-operative pain: Post-operative discomfort > Hernia discomfort
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: pre- and post-operative pain: response missing
7 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Location of symptoms: Not applicable
15 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Location of symptoms: Elsewhere
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Timing of symptoms: Not applicable
15 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Timing of symptoms: After exertion or end of day
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Frequency of symptoms: Not applicable
15 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Frequency of symptoms: Often during day
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Impact of symptoms on activities: Not applicable
15 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: pre- and post-operative pain: Response missing
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Location of symptoms: Not applicable
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Location of symptoms: Bilateral
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Timing of symptoms: Not applicable
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Timing of symptoms: Anytime
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Frequency of symptoms: Not applicable
4 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Impact of symptoms on activities: Not applicable
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Impact of symptoms on activities: Does not disrupt activities
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: pre- and post-operative pain: Not applicable
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: pre- and post-operative pain: post-operative discomfort < Hernia discomfort
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Perception of structure of abdominal wall: Solid
16 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Perception of lump in abdominal wall: No
15 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Perception of lump in abdominal wall: Elsewhere
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Perception of structure of abdominal wall: Solid
4 participants
Quality of Life Questionnaire (QOL) for Patient
Month 24: Perception of lump in abdominal wall: No
4 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Post-operative discomfort: Tingling (dyesthesia, hyperesthesia, hyperpathia)
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Post-operative discomfort: Reduced sensitivity
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Post-operative discomfort: Moderated pain per Visual Analog Scale (VAS)
3 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Post-operative discomfort: Response missing
8 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12 : Post-operative discomfort: No symptoms
14 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Post-operative discomfort: Significant pain
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Post-operative discomfort: Other symptoms
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Frequency of symptoms: All day
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Frequency of symptoms: 24 hours a day
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 1: Frequency of symptoms: Response missing
7 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: Impact of symptoms on activities: Prohibits certain activities
1 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: pre- and post-operative pain: Not applicable
14 participants
Quality of Life Questionnaire (QOL) for Patient
Month 12: pre- and post-operative pain: Post-operative discomfort > Hernia discomfort
1 participants

SECONDARY outcome

Timeframe: Day 0

Population: Surgeons who placed the ProGrip Self-Gripping Polyester Mesh during midline laparotomy procedures.

Surgeon satisfaction on mesh ease of use and manipulability.

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=26 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Surgeon Satisfaction
Mesh shape memory : Satisfactory
24 surgeons
Surgeon Satisfaction
Mesh shape memory : Unsatisfactory
1 surgeons
Surgeon Satisfaction
Mesh shape memory : Not Stated
1 surgeons
Surgeon Satisfaction
Mesh placement - adhesion to the wall
17 surgeons
Surgeon Satisfaction
Mesh placement - absence of laying direction
8 surgeons
Surgeon Satisfaction
Mesh placement - shape memory
5 surgeons
Surgeon Satisfaction
Mesh placement - transparency
8 surgeons
Surgeon Satisfaction
Mesh placement - easy to reposition
12 surgeons
Surgeon Satisfaction
Flexibility of the Mesh : Satisfactory
25 surgeons
Surgeon Satisfaction
Flexibility of the Mesh : Not Stated
1 surgeons
Surgeon Satisfaction
Cuttable : Satisfactory
24 surgeons
Surgeon Satisfaction
Cuttable : Not Stated
2 surgeons

SECONDARY outcome

Timeframe: Month 12, Month 24

Population: Patients who received ProGrip Self-Gripping Polyester Mesh for suture line reinforcement after midline laparotomy, met all of the inclusion criteria, and none of the exclusion criteria.

The Club Hernie Patient Satisfaction Survey is used to determine how satisfied a subject is with the mesh placement.

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=16 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Patient Satisfaction
Month 12: Repeat Procedure Performed = No
14 participants
Patient Satisfaction
Month 12: Repeat Procedure Performed = Response Missing
2 participants
Patient Satisfaction
Month 12: Strength of abdominal wall = Excellent
5 participants
Patient Satisfaction
Month 12: Strength of abdominal wall = Good
5 participants
Patient Satisfaction
Month 12: Strength of abdominal wall = Moderate
1 participants
Patient Satisfaction
Month 12: Strength of abdominal wall = Poor
1 participants
Patient Satisfaction
Month 12: Strength of abdominal wall = response missing
4 participants
Patient Satisfaction
Month 24: Repeat Procedure Performed = No
4 participants
Patient Satisfaction
Month 24: Strength of abdominal wall = Excellent
1 participants
Patient Satisfaction
Month 24: Strength of abdominal wall = Good
3 participants
Patient Satisfaction
Month 24: Strength of abdominal wall = Poor
0 participants

SECONDARY outcome

Timeframe: Day 0

Population: Surgeons who placed the ProGrip Self-Gripping Polyester Mesh during midline laparotomy procedures.

Time to position the mesh

Outcome measures

Outcome measures
Measure
Patients Treated With ProGrip Self-Gripping Polyester Mesh: Gripping Polyester Mesh
n=20 Participants
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled receiving the ProGrip™ Self-Gripping Polyester Mesh
Surgeon Satisfaction
8.0 minutes
Standard Deviation 6.34

Adverse Events

Patients Treated With ProGrip™ Self-Gripping Polyester Mesh

Serious events: 10 serious events
Other events: 17 other events
Deaths: 2 deaths

Serious adverse events

Serious adverse events
Measure
Patients Treated With ProGrip™ Self-Gripping Polyester Mesh
n=32 participants at risk
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled will receive the ProGrip™ Self-Gripping Polyester Mesh
Infections and infestations
Septic shock
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Anastomotic leak
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Anastomotic ulcer
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Vasoplegia syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Wound evisceration
6.2%
2/32 • Number of events 2 • surgery to the 24-month visit
Metabolism and nutrition disorders
Diabetic metabolic decompensation
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Musculoskeletal and connective tissue disorders
Compartment syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Renal and urinary disorders
Acute kidney injury
6.2%
2/32 • Number of events 2 • surgery to the 24-month visit
Respiratory, thoracic and mediastinal disorders
Acute respiratory distress syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Surgical and medical procedures
Small intestinal resection
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Vascular disorders
Haematoma
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Vascular disorders
Shock
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Cardiac disorders
Arrhythmia
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Gastrointestinal fistula
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Gastrointestinal ischaemia
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Ileus
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Intra-abdominal fluid collection
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Oesophageal ulcer
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Pancreatitis acute
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
General disorders
Multiple organ dysfunction syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
General disorders
Swelling
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Infections and infestations
Escherichia infection
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Infections and infestations
Sepsis
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit

Other adverse events

Other adverse events
Measure
Patients Treated With ProGrip™ Self-Gripping Polyester Mesh
n=32 participants at risk
ProGrip™ Self-Gripping Polyester Mesh: All subjects enrolled will receive the ProGrip™ Self-Gripping Polyester Mesh
Cardiac disorders
Arrhythmia
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Diarrhoea
6.2%
2/32 • Number of events 2 • surgery to the 24-month visit
Gastrointestinal disorders
Fistula of small intestine
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Gastrointestinal fistula
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Gastrointestinal ischaemia
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Ileus
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Impaired gastric emptying
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Intra-abdominal fluid collection
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Oesophageal ulcer
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Pancreatitis acute
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Gastrointestinal disorders
Steatorrhoea
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
General disorders
Inflammation
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
General disorders
Multiple organ dysfunction syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
General disorders
Swelling
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Infections and infestations
Escherichia infection
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Infections and infestations
Sepsis
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Infections and infestations
Septic shock
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Infections and infestations
Vascular device infection
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Anastomotic leak
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Anastomotic ulcer
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Incisional hernia
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Seroma
6.2%
2/32 • Number of events 2 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Vasoplegia syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Injury, poisoning and procedural complications
Wound evisceration
6.2%
2/32 • Number of events 2 • surgery to the 24-month visit
Investigations
Investigation
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Metabolism and nutrition disorders
Diabetic metabolic decompensation
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Musculoskeletal and connective tissue disorders
Compartment syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Nervous system disorders
Hypoaesthesia
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Renal and urinary disorders
Acute kidney injury
6.2%
2/32 • Number of events 2 • surgery to the 24-month visit
Renal and urinary disorders
Urinary retention
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Respiratory, thoracic and mediastinal disorders
Acute respiratory distress syndrome
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Surgical and medical procedures
Small intestinal resection
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Vascular disorders
Deep vein thrombosis
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Vascular disorders
Haematoma
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit
Vascular disorders
Shock
3.1%
1/32 • Number of events 1 • surgery to the 24-month visit

Additional Information

Marion Blanc

Medtronic

Phone: +33 4 74 08 90 00

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place